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Abstract
Background: Reliability of real-time PCR (RT-qPCR) data is dependent on the use of appropriate
reference gene(s) for normalization. To date, no validated reference genes have been reported for
normalizing gene expression in human myocardium. This study aimed to identify validated
reference genes for use in gene expression studies of failed and non-failed human myocardium.
Methods: Bioinformatic analysis of published human heart gene expression arrays (195 failed
hearts, 16 donor hearts) was used to identify 10 stable and abundant genes for further testing. The
expression stability of these genes was investigated in 28 failed and 28 non-failed human
myocardium samples by RT-qPCR using geNorm software.
Results: Signal recognition particle 14 kDa (SRP14), tumor protein, translationally-controlled 1
(TPT1) and eukaryotic elongation factor 1A1 (EEF1A1) were ranked the most stable genes. The
commonly used reference gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was ranked
the least stable of the genes tested. The normalization strategy was tested by comparing RT-qPCR
data of both normalized and raw expression levels of brain natriuretic peptide precursor (NPPB),
a gene known to be up-regulated in heart failure. Non-normalized levels of NPPB exhibited a
marginally significant difference between failed and non-failed samples (p = 0.058). In contrast,
normalized NPPB expression levels were significantly higher in heart-failed patients compared with
controls (p = 0.023).
Conclusion:  This study used publicly available gene array data to identify a strategy for
normalization involving two reference genes in combination that may have broad application for
accurate and reliable normalization of RT-qPCR data in failed and non-failed human myocardium.
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Background
Analysis of gene expression levels has become increasingly
important in biological research, providing insight into
the complex regulatory networks that underlie health and
disease [1]. Quantitative real-time PCR (RT-qPCR) is one
of the most sensitive, specific, and widely-used methods
for measuring the expression levels of selected genes [2,3].
Accuracy of RT-qPCR data is reliant on appropriate nor-
malization of individual samples, and sub-optimal nor-
malization is a common pitfall of RT-qPCR analyses
[1,2,4]. There are many sources of variation in gene
expression measurements, including differences in cell
number, transcriptional efficiency, mRNA integrity, and
differences in efficiency of RNA extraction and variability
of cDNA synthesis between samples. While a number of
strategies have been applied to account for inter-sample
variation, the use of two or more reference genes is cur-
rently the favored approach for accurate and reliable nor-
malization of the mRNA fraction [2,5].
Among the most commonly used reference genes in RT-
qPCR are glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and β-actin [6]. These genes were introduced
for normalization when mRNA expression was assessed
using semi-quantitative methods, such as Northern blot-
ting and RNase protection, because of their relatively high
abundance in numerous cell-types [1,4]. However, the
increased sensitivity of RT-qPCR demands a significantly
greater stringency for reference gene selection [2,5]. Previ-
ous studies have demonstrated that the expression levels
of classical reference genes can vary markedly across cells,
tissues and experimental conditions, including heart cells
and tissues [7,8]. More stable alternatives exist, although
these tend to be specific to the tissue under investigation
[1,6,9,10]. To date, no validated universal or human
heart-specific reference genes have been identified.
To select optimal reference genes for RT-qPCR analysis of
human myocardium, we screened human heart gene
expression data from a published microarray study and
investigated gene abundance and expression stability. We
validated the top-ranked candidate reference genes in an
independent set of human myocardium samples obtained
from heart transplant patients and heart-healthy donors,
and identified the minimum set required for accurate and
reliable normalization of RT-qPCR data in failed and non-
failed human myocardium.
Methods
Candidate gene selection
To select candidate reference genes for subsequent testing
by RT-qPCR, publicly available microarray data from
explanted human myocardium was screened to identify
transcripts with stable and abundant expression. Abun-
dant transcripts were selected to ensure robust measure-
ment by RT-qPCR in all samples. Affymetrix gene
expression profiles generated from left ventricle myocar-
dium from 195 heart transplant recipients with advanced
ischemic or idiopathic cardiomyopathy and 16
unmatched heart donors [11] were obtained from the
NCBI GEO database (GEO accession GSE5406, http://
www.ncbi.nlm.nih.gov). These data were derived from
Affymetrix HG-U133A microarrays, each consisting of
22,283 probe sets representing approximately 13,000
genes. MAS 5.0 [12] normalized data were used to calcu-
late the mean and standard deviation of the expression
intensity for each probe set across all samples, using the R
software package [13]. The 5% of probe sets with the
smallest standard deviations (i.e., the least variable) were
then identified, and of those, any probe set with a mean
expression intensity of greater than 10 on the log2 scale
was selected for assessment as a candidate reference for
RT-qPCR analysis. For comparison, the expression stabil-
ity and abundance of 50 genes previously used or pro-
posed by prior studies as reference genes [6,10,14] were
also screened for abundance and stability across all probes
for identification of candidate reference genes.
Patient samples
Tissue from the left ventricular free wall of the myocar-
dium was obtained from explanted failed hearts from
heart transplant recipients at the Cleveland Clinic Foun-
dation (n = 28). Non-failed heart tissue was obtained
from unmatched organ donors through Lifebanc of
Northeast Ohio (n = 28). Tissue handling was as previ-
ously described [15,16]. The investigation was approved
by the Cleveland Clinic Internal Review Board (ethics
approval IRB 2378) and all patients provided informed
consent. The study adhered to the principles outlined in
the Declaration of Helsinki and Title 45, US Code of Fed-
eral Regulation, Part 46, Protection of Human Subjects,
revised November 13, 2001, effective December 13, 2001.
All procedures followed were in accordance with institu-
tional guidelines.
Sample preparation
Frozen tissue blocks (previously stored at -80°C, mean
weight ± standard deviation = 181 ± 81 mg) were placed
in pre-chilled tubes containing TRIzol®  (Invitrogen,
Carlsbad, CA) and immediately subjected to automated
grinding in a Mixer Mill MM301 (Retsch, Haan, Ger-
many). Total RNA was isolated with chloroform and puri-
fied using RNeasy Midi columns in a total volume of 300
μL (Qiagen, Valencia, CA) according to the manufac-
turer's instructions. RNA yield and purity was determined
using a Nanodrop spectrophotometer (Nanodrop Tech-
nologies, Montanin, DE). The mean RNA concentration
and 260:280 ratio (± standard deviation) was 749 ± 271
ng/μL and 2.05 ± 0.03, respectively. The integrity of the
RNA was assessed with gel electrophoresis. All samplesBMC Medical Genomics 2008, 1:64 http://www.biomedcentral.com/1755-8794/1/64
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were digested with DNase I (Invitrogen, Carlsbad, CA).
First strand cDNA synthesis was performed from 2 μg of
total RNA with oligodT primers and Superscript III, fol-
lowed by RNase H digestion (Invitrogen, Carlsbad, CA) as
previously described [17].
Real-time PCR
Primers for all 10 candidate reference genes were designed
using Primer3 software [18] within regions spanned by
the Affymetrix probe set target sequences (Table 1). At
least one primer in every primer pair was designed across
an exon/exon boundary to prevent amplification of any
dsDNA transcripts not removed by digestion with DNase
I. Affymetrix probe sequences were obtained from the
Affymetrix NETAFFX Analysis Centre http://www.affyme
trix.com/analysis/index.affx. Alignments of Affymetrix
probe set target sequences with mRNA and genomic DNA
sequences for each gene were performed with Genious
version 2.0.01 software. RT-qPCR reactions were per-
formed in duplicate in a Rotor-Gene 3000 (Corbett
Research, Sydney, Australia) using SYBR Green I detection
of dsDNA synthesis. Reactions (20 μL) contained 1 μL
template cDNA, 1× PCR buffer, 1.5 mM MgCl2, 0.2 mM
dNTPs (Fermentas, Glen Burnie, MD), 0.5 mM forward
and reverse primers, 5× SYBR Green I (Roche Diagnostics,
Mannheim, Germany) and 1 U Taq-Ti DNA polymerase
(Fisher Biotec, West Perth, Australia). The cycling condi-
tions comprised 2 mins polymerase activation at 94°C
followed by 30 cycles of 94°C for 10s, 56°C for 20s, and
68°C for 10s. On completion, amplimers were exposed to
a temperature gradient from 79–95°C (melt curve) to
confirm that a single product had been amplified. For
each sample the Ct value (the fluorescent point at which
the reactions are compared) was fitted to a standard curve
consisting of five serial dilution points (in triplicate) of
purified DNA template (amplicon derived, copy number
ranging from ~109 to ~105 copies) and a no-template
control. The reaction efficiency for each primer set is
detailed in Table 1. The mean standard deviation of Ct
values for duplicated samples was 0.10. Quantification of
each sample was performed using Rotor-Gene software
version 6.1.
NPPB expression levels were determined using a Taqman
gene expression assay with inventoried probes (assay id #
Hs00173590_m1, Applied Biosystems, Foster City, CA).
Reactions (20 μL) were performed in triplicate on a 7500
Fast real-time PCR system (Applied Biosystems) in stand-
ard mode according to manufacturer's instructions. Sam-
ples were quantified using a standard curve consisting of
five serial dilution points (in triplicate) of purified DNA
template (amplicon derived, copy number ranging from
1.13 × 108 – 1.13 × 104 copies) and a no-template con-
trol. Reaction efficiency was 101.2%. The mean standard
deviation of Ct values for duplicate samples was 0.16.
Quantification was performed with 7500 Software ver-
sion 2.0 (Applied Biosystems).
Evaluation of candidate reference genes using GeNorm
The Visual Basic Application geNorm version 3.4 [5,14]
was used to evaluate the expression stability of each gene,
determine the ideal number of genes required for normal-
ization, and calculate individual normalization factors
based on the expression levels of the best reference genes.
Table 1: Real-time PCR primers
Primer Sequence Tm Length (bp) Efficiency (%)
GAPDH Forward GCTCATTTCCTGGTATGACAACG 63 213 92.8
Reverse AGGGGTCTACATGGCAACTG 60
RPL22 Forward CCATGGCTCCTGTGAAAAAG 61 219 91.6
Reverse TCACGGTGATCTTGCTCTTG 60
TPT1 Forward AAATGTTAACAAATGTGGCAATTAT 58 164 95.9
Reverse AACAATGCCTCCACTCCAAA 61
RPS4X Forward GATCCCCTCATCAAGGTGAA 60 243 78.7
Reverse GCCCTTGCCAATAACAAAAA 60
RPL13A Forward CGCCCTACGACAAGAAAAAG 60 206 96.9
Reverse CCGTAGCCTCATGAGCTGTT 60
RPL23A Forward GCTCCCAGGAGAAACAAGC 60 201 92.2
Reverse ATCAGGCCGAATCAGGGTGTT 65
EEF1A1 Forward CTTTGGGTCGCTTTGCTGTT 63 183 95.0
Reverse CCGTTCTTCCACCACTGATT 60
RPL41 Forward ATGAGAGCCAAGTGGAGGAA 60 219 94.0
Reverse TCAGAGGGCGATGAAGTTCT 60
RNPS1 Forward ACCCATGGTAGTTGCTGCTC 60 104 95.3
Reverse AGCTGGCTCTCCACTCACTC 60
SRP14 Forward CAGATGGCTTATTCAAACCTCCT 61 181 99.9
Reverse ATGCCCTTTACTGTGCTGCT 60BMC Medical Genomics 2008, 1:64 http://www.biomedcentral.com/1755-8794/1/64
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In geNorm analysis, the calculated gene stability measure
(M) relies on the principle that the ratio of two ideal ref-
erence genes will be identical in all samples. M is calcu-
lated as the average pairwise variation between a
particular gene and all other genes in the analysis.
Decreasing expression stability occurs when one or more
of the genes is not constantly expressed. At each step in the
analysis the least stable gene (highest M-value) is
excluded and M is recalculated. This process continues in
a step-wise manner until the two most stable genes
remain. To determine the optimum number of genes for
normalization, the two most stable genes are used as a
starting point. Genes are added sequentially (from most
stable to least stable) until the pairwise variation between
two sequential normalization factors drops below a set
threshold, indicating that the prior gene set is sufficient
for accurate normalization [5]. A large variation indicates
that the added gene has a significant effect and should
preferably be included, provided it is stably expressed.
However, genes that are less stably expressed also give
high pairwise variation because they have a different pat-
tern of expression compared with the more stably
expressed genes. Therefore, to achieve accurate normaliza-
tion, less stable genes should not be included in calcula-
tion of the normalization factor, despite their high
pairwise variation values. Based on their findings Vandes-
ompele et. al. recommended setting the pairwise variation
threshold at 0.15 [5].
Using the geNorm algorithm, normalization factors were
calculated by transforming Ct values into quantities
(using standard curves or the comparative Ct method),
setting the highest relative quantity for each gene to 1, and
scaling the expression value for all other samples to a pro-
portion relative to this highest value. Normalization fac-
tors using multiple genes were determined by calculating
the geometric mean of the scaled reference genes.
Statistical analyses
Univariate analyses were performed using analysis of var-
iance to compare gene expression levels in heart-failed
and non heart-failed groups. Gene expression data dis-
played consistently skewed distributions and hence these
data were log-transformed and geometric means with
95% confidence intervals have been reported. Correla-
tions between expression levels of ribosomal genes and
between normalization factors generated with two, three,
four or five genes were calculated using Pearson correla-
tion coefficients. All statistical analyses were performed
with SPSS version 16 (SPSS Inc., Chicago, IL). A p-value <
0.05 was taken to indicate statistical significance.
Results
Twenty genes were identified as being represented by at
least one probe set exhibiting low variation and high
abundance among all samples (Figure 1). From this anal-
ysis 7 genes were selected as candidate reference genes for
further testing with RT-qPCR based on whether other
probe sets for that gene also had small variance and high
abundance across samples. The genes selected were
GAPDH, RPL22, RPS4X, TPT1, RPL23A, RPL41 and
SRP14 (see Table 2 for full gene name, chromosomal loca-
tion, function and expression levels in heart-failed and
control tissue). In addition, analysis of 50 genes previ-
ously used or proposed by prior studies as reference genes
[6,10,14] identified an additional three genes with small
variance across probes: RPL13A, EEF1A1 and RNPS1
(Table 2, see Additional file 1 for Affymetrix probe inten-
sities for all 50 genes). Thus a total of 10 genes were
selected as candidates for testing, of which 4 encoded
ribosomal proteins (RPL22, RPL23A, RPL41 and RPL13A)
and are involved in protein biosynthesis. Because the
expression levels of the ribosomal genes were tightly cor-
related (Table 3) and co-regulation of genes may con-
found geNorm analyses, only one of the ribosomal
proteins could be included in the analysis. A preliminary
analysis identified RPL13A as the most stable ribosomal
gene for inclusion in the geNorm analysis (data not
shown). The remaining ribosomal genes were excluded.
There was no relationship between the functional class of
any of the other genes (Table 2).
Genes were ranked from least stable to most stable by
geNorm analysis: GAPDH, RPS4X, RPL13A, RNPS1,
EEF1A1, TPT1/SRP14 (Figure 2). All genes had high
expression stability (M-values <1), below the default limit
of M = 1.5, except for GAPDH. GAPDH was considerably
more variably expressed (M-value = 1.94). GeNorm anal-
ysis indicated that the top five most stable genes would be
needed for reliable normalization of RT-qPCR data
(geNorm recommended threshold = 0.15, Figure 3).
Univariate analysis showed that the expression levels of
all candidate reference genes except for TPT1 (p = 0.080),
EEF1A1 (p = 0.116) and RNPS1 (p = 0.061) were signifi-
cantly lower in the myocardium of end-stage heart failure
patients compared with non heart-failed donors (Table
2). Thus, these genes have utility as a reference within
heart-failed myocardium samples or non-failed donor
myocardium samples separately, but not for comparing
gene expression between these groups. Notably expres-
sion levels of the commonly used reference gene, GAPDH,
differed significantly between failed and non-failed myo-
cardium (p = 0.015, Table 2).
Within heart-failed and non-failed myocardium samples
separately, we explored whether fewer than five reference
genes could be used for normalization. A series of normal-
ization factors were generated for each sample using geo-
metric means of the top two, three or four most stableBMC Medical Genomics 2008, 1:64 http://www.biomedcentral.com/1755-8794/1/64
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genes and correlated with the original set of normaliza-
tion factors generated using all five top-ranked genes. Very
tight correlation was observed between normalization fac-
tors for all gene sets (Pearson correlation coefficients,
heart-failed samples: 0.976–0.995, p < 0.001; non-failed
controls: 0.973–0.992, p < 0.001). Figure 4 illustrates the
tight correlation between normalization factors generated
with the top two (SRP14 and TPT1) and the top five most
stable genes, indicating that as few as two genes may be
sufficient for reliable normalization within failed and
non-failed myocardium. Normalization factors generated
using SRP14 and TPT1 were not correlated with GAPDH
levels, in failed myocardium (Pearson correlation coeffi-
cient = -0.153, p = 0.436) or non-failed myocardium
(Pearson correlation coefficient = -0.181, p = 0.356), sug-
gesting that normalization of gene expression data with
GAPDH in these samples would be inappropriate.
The expression levels of TPT1, EEF1A1 and RNPS1, did
not differ significantly between failed and non-failed
human myocardium samples (Table 2). These genes
ranked among the top four most stable genes of those
tested (Figure 2). Normalization of gene expression in
failed and non-failed myocardium using these genes was
tested by comparing normalized and raw expression levels
of NPPB, a gene known to be up-regulated in heart-failed
heart tissue. In the raw data NPPB levels were higher in
heart-failed patients compared with controls, but the dif-
ference did not reach statistical significance (p = 0.058,
Table 4). In normalized data, NPPB levels were signifi-
Selection of candidate reference genes Figure 1
Selection of candidate reference genes. Expression levels of probe sets for genes with one or more probe sets among the 
top 20 most stable and abundantly expressed across all samples, identified from screening publicly available Affymetrix gene 
expression profiles of left ventricle myocardium from 195 heart transplant recipients and 16 unmatched heart donors [11] 
(GEO accession GSE5406, http://www.ncbi.nlm.nih.gov). GAPDH, RPL22, RPS4X, TPT1, RPL23A, RPL41 and SRP14 genes 
were selected as candidate reference genes (shown in red), based on their high abundance and consistent expression across 
the majority of probe sets. Affymetrix probe set nomenclature is preceded by the gene symbol. Boxes indicate median and 
interquartile range, whisker length is 150% of the interquartile range. Observations beyond the whiskers are denoted by open 
circles.B
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Table 2: Candidate cardiac reference genes ranked in order of abundance
UniGene accession Gene symbol Gene name Gene ontology 
biological process
Location HF patients* 
(copy #/μg total RNA)
Controls* 
(copy #/μg total RNA)
p-value 
(HF vs controls)
Hs.479728 GAPDH glyceraldehyde-3-
phosphate dehydrogenase
glucose metabolism, 
glycolysis, translational 
initiation, cell 
communication,
12p13 1.13 × 109
(0.91 – 1.40 × 109)
1.65 × 109
(1.33 – 2.05 × 109)
0.015
Hs.515329 RPL22 ribosomal protein L22 protein biosynthesis 1p36 1.48 × 107
(1.13 – 1.95 × 107)
2.80 × 107
(2.13 – 3.68 × 107)
0.002
Hs.374596 TPT1 tumor protein, 
translationally-controlled 1
calcium and microtubule-
binding
13q12 1.00 × 107
(0.60 – 1.69 × 107)
1.93 × 107
(1.15–3.26 × 107)
0.080
Hs.446628 RPS4X ribosomal protein S4, X-
linked
regulation of cell cycle, 
protein biosynthesis, 
development, cell 
proliferation
Xq13 0.89 × 107
(0.62 – 1.27 × 107)
1.99 × 107
(1.39 – 2.86 × 107)
0.003
Hs.523185 RPL13A ribosomal protein L13a protein biosynthesis 19q13 2.33 × 106
(1.39–3.90 × 106)
6.24 × 106
(3.73 – 10.45 × 106)
0.009
Hs.419463 RPL23A ribosomal protein L23a protein biosynthesis 17q11 2.44 × 106
(1.78 – 3.34 × 106)
5.51 × 106
(4.02 – 7.56 × 106)
0.001
Hs.490287 EEF1A1 Eukaryotic elongation 
factor 1A1
translational elongation 6q14 2.44 × 106
(1.42 – 4.17 × 106)
4.47 × 106
2.61–7.65 × 106
0.116
Hs.112553 RPL41 ribosomal protein L41 protein biosynthesis 12q13 1.78 × 106
(1.08 – 2.93 × 106)
4.70 × 106
(2.86 – 7.73 × 106)
0.008
Hs.355643 RNPS1 RNA binding protein S1 transcription, RNA splicing 16p13 6.19 × 105
(4.04 – 9.48 × 105)
11.00 × 105
(7.19 – 16.85 × 105)
0.061
Hs.533732 SRP14 signal recognition particle 
14 kDa
protein targeting 15q22 4.03 × 105
(2.30 – 7.08 × 105)
10.76 × 105
(6.14 – 18.90 × 105)
0.017
* Transcript copy number per μg total RNA, geometric mean (95% confidence interval). HF = heart failureBMC Medical Genomics 2008, 1:64 http://www.biomedcentral.com/1755-8794/1/64
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cantly higher in heart-failed patients compared with con-
trols (p = 0.023, Table 4). Removing the least stable gene,
RNPS1, from the pool of reference genes only marginally
affected the results (p = 0.024, Table 4). Mean NPPB levels
were almost identical to data normalized with RNPS1
included, indicating that as few as two genes (TPT1 and
EEF1A1) may be sufficient for reliable normalization.
Normalization factors generated using TPT1, EEF1A1 and
RNPS1 were not correlated with GAPDH levels (Pearson
correlation coefficient = -0.085, p = 0.535). Normalizing
NPPB to GAPDH alone gave a larger difference between
failed and non-failed myocardium (4.2-fold, p = 0.012,
Table 4) compared with data normalized with TPT1,
EEF1A1 and RNPS1 combined (3.4-fold, p = 0.023, Table
4).
Discussion
Validation of tissue-specific reference genes is a funda-
mental first-step in RT-qPCR analysis. We have identified
two genes, SRP14 and TPT1, that in combination can be
used for accurate and reliable normalization of RT-qPCR
gene expression data within failed human myocardium
and non-failed human myocardium separately, and two
genes, TPT1 and EEF1A1 that are more stably expressed
than GAPDH and may be used for normalization of RT-
qPCR data when comparing gene expression levels
between failed and non-failed human myocardium sam-
ples.
The physiological functions of SRP14, TPT1 and EEF1A1
relate to important independent cellular processes,
emphasizing their utility as reference genes. SRP14 is a
component of the signal recognition particle, a univer-
sally conserved ribonucleoprotein complex that mediates
Table 3: Pearson correlations of expression levels of ribosomal 
genes
RPL13A RPL22 RPL23A RPL41
RPL13A 1.00 0.851
p < 0.001
0.866
p < 0.001
0.952
p < 0.001
RPL22 1.00 0.886
p < 0.001
0.831
p < 0.001
RPL23A 1.00 0.903
p < 0.001
RPL41 1.00
Average expression variability of reference genes (M), during stepwise exclusion of the least stable gene Figure 2
Average expression variability of reference genes (M), during stepwise exclusion of the least stable gene. At 
each step the most variable gene (highest M-value) is excluded and M is recalculated. This process continues in a step-wise 
manner until the two most stable genes remain. The figure indicates that GAPDH is least stably expressed relative to the other 
genes, and that SRP14 and TPT1 have the most stable expression.
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targeting of membrane and secretory proteins to the endo-
plasmic reticulum [19]. TPT1 encodes the abundant and
highly conserved translationally controlled tumor protein
(TCTP), which is reported to play a role in cell growth and
cell cycle progression [20]. EEF1A1 is a component of the
alpha subunit of the elongation factor-1 complex, which
facilitates the enzymatic delivery of aminoacyl tRNAs to
the ribosome [21]. Notably, TPT1 is expressed in a tissue-
and development-specific manner, suggesting that its util-
ity as a reference gene in human myocardium may be lim-
ited to analyses in adult hearts [22].
To date, reference genes have been identified for a wide
range of species, tissue types, experimental conditions and
disease states. The typical methodological approach used
in these studies has been to test a selection of commonly
used reference genes such as GAPDH, β-actin, α-tubulin,
hypoxanthine phosphoribosyl-transferase 1 and 18S RNA
to identify the most stable combination specific to the
sample and experimental conditions under investigation
[23-29]. A small number of studies have reported that
none of the traditional reference genes tested were appro-
priate for use in the particular setting investigated [30-32].
More recently, a genome-wide approach has been
employed, where candidate reference genes selected from
publicly available microarray data has lead to identifica-
tion of novel transcripts that are more stably expressed
than commonly used reference genes. These studies can
be broadly classified into two groups: those that screen
expression data from a diverse range of tissue types and
species to identify transcripts that are stably and ubiqui-
tously expressed and may therefore have board utility as
reference genes [6,10,33-35], and those that screen array
data from a specific tissue or disease setting to identify a
set of candidate genes for validation in an independent
sample set, as in the present study. To date, studies in the
latter group have validated panels of novel reference genes
in human normal and cancerous lung tissues [36,37],
human normal and tumor gastrointestinal tissues [38],
human embryonic stem cells [39], porcine mammary tis-
sue [40], canine osteoarthritic joint tissue [41], barley [42]
and lymphoblastoid cell lines and fibroblasts [43]. Nota-
bly, Peltier et. al. have identified a set of microRNA refer-
ences for use in RT-qPCR analysis of microRNAs in
Determination of the ideal number of reference genes for normalization Figure 3
Determination of the ideal number of reference genes for normalization. Using the two most stable genes as a start-
ing point (SRP14 and TPT1), genes are added sequentially (from most stable to least stable) until the pairwise variation 
between two sequential normalization factors drops below the recommended threshold of 0.15, indicating that the prior gene 
set is sufficient for accurate normalization. Variation greater than 0.15 indicates that the added gene has a significant effect and 
should preferably be included, provided it is stably expressed. This figure shows that the sixth most stable gene (RPS4X) is not 
required for reliable normalization of RT-PCR data.
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normal and cancerous human solid tumors [44]. How-
ever, no validated universal reference genes have been
identified.
In the present study, screening of Affymetrix cardiac
expression data enabled us to identify four novel genes
and six genes commonly used, or recommended for use,
as references in human tissue, as potentially suitable for
use in heart tissue RT-qPCR analyses. Interestingly, there
were striking similarities between the genes we identified
as stably expressed in cardiac microarrays and those iden-
tified in a recent meta-analysis of 13,629 human gene
arrays of a diverse range of cell types and experimental
conditions [6]. Both studies identified SRP14, RPL13A
and RPL22 as being highly stably expressed, and found an
over-representation of ribosomal genes among the top
ranked transcripts. However, we also identified novel can-
didate genes specific to heart tissue, including TPT1, one
of the most stably expressed genes in our analysis. Our
finding that all genes selected were more stably expressed
than GAPDH is consistent with an analogous study in gas-
trointestinal normal and tumor tissues [38], where
GAPDH was the less stably expressed genes in tissue from
stomach, small intestine, liver, and lymph nodes com-
pared with expression of 8 candidate reference genes
selected from analysis of publicly available Affymetrix
array data.
Correlation of individual normalization factors generated using the top five most stable genes and the top two most stable  genes Figure 4
Correlation of individual normalization factors generated using the top five most stable genes and the top two 
most stable genes. Tight correlation between normalization factors indicates that as few as two genes may be sufficient for 
reliable normalization of RT-qPCR data for (A) heart-failed myocardium and (B) non-failed donor myocardium. PCC = Pearson 
correlation coefficient.
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PCC=0.976
p<0.001
PCC=0.0.973
p<0.001
Table 4: Normalization of NPPB using fewer than three reference genes
Genes used for 
normalization
Correlation with normalization factors 
using TPT1, EEF1A1 & RNPS1
Normalized NPPB levels 
(geometric mean and 95% CI, copy #/μg total RNA)
PCC p-value for correlation HF patients Controls p-value (HF vs controls)
TPT1, EEF1A1 & 
RNPS1
1.000 - 11.3 × 106
(5.3 – 24.0 × 106)
3.3 × 106
(1.5 – 6.9 × 106)
0.023
TPT1 & EEF1A1 0.989 <0.001 11.2 × 106
(5.3 – 23.9 × 106)
3.3 × 106
(1.5 – 7.0 × 106)
0.024
GAPDH -0.085 0.535 77.5 × 106
(35.6 – 168.9 × 106)
18.5 × 106
(8.5 – 40.4 × 106)
0.012
Raw data - - 14.1 × 106
(6.6 – 30.4 × 106)
4.9 × 106
(2.3 – 10.6 × 106)
0.058
PCC = Pearson correlation coefficient, HF = heart failureBMC Medical Genomics 2008, 1:64 http://www.biomedcentral.com/1755-8794/1/64
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GeNorm [5] is one of several statistical algorithms that
evaluate the relative expression stability of genes on the
basis of non-normalized expression levels. Other pro-
grams for assessing gene stability include Best keeper [45],
NormFinder [46], Global Pattern Recognition [47] and
equivalence tests [48]. These programs have provided a
rational basis for selection of reference genes for normali-
zation of RT-qPCR data. While the relative gene stability
rankings may vary subtly depending on which algorithm
is applied [41,49,50], use of multiple reference genes pro-
vides a considerably more robust result compared with
relying on a single RNA transcript [5]. This reflects the het-
erogeneity inherent in human samples related to age, gen-
der, ethnicity, and gene-environment interactions. In the
present study all donors were on life-support as a result of
head trauma or cerebral vascular accident and thus the
gene expression profile of the donor heart samples may
have been affected by the traumatic events and acute drug
treatments that preceded the donation of tissue. Similarly,
gene expression in heart-failed tissue will vary depending
on the etiology and duration of heart failure and chronic
and acute drug treatments.
GeNorm analysis enables the ideal number of reference
genes required for reliable normalization to be deter-
mined. Our analysis indicated that the top five genes
would be required for accurate normalization of RT-qPCR
data within failed and non-failed human myocardium,
however, the number of genes used needs to be a balance
between accuracy and practical considerations. Realisti-
cally, if two relatively stable genes have been identified, it
is unnecessary to add more genes if the normalization fac-
tor does not change markedly when they are included. We
were able to demonstrate that as few as two genes may be
sufficient for normalization in human myocardium
(SRP14 and TPT1 for analysis within failed or non-failed
tissue and TPT1 and EEF1A1 for comparisons of gene
expression between these groups), as the variation
between normalization factors generated using two, three,
four or five genes was very small. Furthermore, when com-
paring NPPB levels between failed and non-failed myocar-
dium, removal of the least stable gene, RNPS1, impacted
minimally on normalized NPPB levels, suggesting that
TPT1 and EEF1A1 may be sufficient for normalization.
This reflects the uniformity in expression stability across
the top-ranked genes (Figure 2) and is equivalent to using
a pairwise variation threshold of 0.23.
Several studies have demonstrated how a single, unvali-
dated reference gene can generate biased results if it is
itself altered by the experimental conditions [5,51-53], In
contrast to GAPDH, the expression levels of TPT1 and
EEF1A1 did not differ significantly between failed and
non-failed human myocardium samples, and they were
ranked as being considerably more stably expressed. How-
ever, because expression of both genes tended to be lower
in failed myocardium compared with non-failed myocar-
dium, TPT1 and EEF1A1 require further validation in a
larger sample to confirm that their expression levels do
not differ between these groups. Normalizing NPPB
expression to GAPDH alone gave a greater difference in
NPPB levels between failed and non-failed myocardium
than the data normalized to TPT1 and EEF1A1. However,
the expression levels of GAPDH were lower in failed heart
samples compared with healthy hearts, and this will have
artificially skewed the data. Normalizing NPPB expression
to TPT1 and EEF1A1 gave a modestly significant differ-
ence in NPPB levels between failed and non-failed myo-
cardium that is more likely to reflect the true level of
expression of NPPB in these two groups. In particular our
finding that GAPDH is differentially expressed in failing
and non-failing myocardium has implications for previ-
ous RT-qPCR studies of human myocardium that have
used GAPDH for normalization without validation.
We have identified reference genes for both failing and
non-failing human myocardium that have significantly
improved stability compared with the commonly used
reference gene, GAPDH (SRP14 and TPT1 for analysis
within failed or non-failed tissue and TPT1 and EEF1A1
for comparisons of gene expression between these
groups). Our findings suggest that routine normalization
of RT-qPCR data in human myocardium with GAPDH
should be avoided as it was the least stably expressed of all
genes tested. This highlights the importance of validating
reference genes for normalization of RT-qPCR data. The
reference genes identified in this study will enable more
reliable interpretation of RT-qPCR results in these tissues.
Whilst TPT1 and EEF1A1 require further validation in a
larger study, these findings serve as a basic guideline for
reference gene selection in human myocardium.
Conclusion
This study has identified a strategy for normalization of
cardiac gene expression involving two reference genes,
SRP14 and TPT1, that in combination may have broad
application for accurate and reliable normalization of RT-
qPCR data within failed human myocardium and non-
failed human myocardium separately. In addition, for
comparisons of gene expression between failed and non-
failed human myocardium TPT1 and EEF1A1, in combi-
nation, may provide a more reliable reference than
GAPDH for normalization of RT-qPCR data for these
analyses.
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